Skip to content
perpustakaan@upi.edu
+62 859 5999 9300
Home
About
Search Options
Search History
Advanced Search
Help
FAQ
Ask Librarian
Contact
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Safety and immunogenicity of N...
Text this
Text this:
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
Number:
Provider:
Select your carrier
Cricket
T Mobile
Verizon
Virgin Mobile